Home
>
National Drug Code (NDC)
>
ClindaMax
ClindaMax - 0462-0390-30 - (clindamycin phosphate)
Drug Information of ClindaMax
| Product NDC: | 0462-0390 |
| Proprietary Name: | ClindaMax |
| Non Proprietary Name: | clindamycin phosphate |
| Active Ingredient(s): | 10 mg/g & nbsp; clindamycin phosphate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ClindaMax
| Product NDC: | 0462-0390 |
| Labeler Name: | PharmaDerm, A division of Nycomed US Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA064160 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091001 |
Package Information of ClindaMax
| Package NDC: | 0462-0390-30 |
| Package Description: | 1 TUBE in 1 CARTON (0462-0390-30) > 30 g in 1 TUBE |
NDC Information of ClindaMax
| NDC Code | 0462-0390-30 |
| Proprietary Name | ClindaMax |
| Package Description | 1 TUBE in 1 CARTON (0462-0390-30) > 30 g in 1 TUBE |
| Product NDC | 0462-0390 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clindamycin phosphate |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20091001 |
| Marketing Category Name | ANDA |
| Labeler Name | PharmaDerm, A division of Nycomed US Inc. |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 10 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
